Ignite Creation Date:
2025-12-24 @ 1:29 PM
Ignite Modification Date:
2026-02-24 @ 11:00 AM
Study NCT ID:
NCT02106195
Status:
COMPLETED
Last Update Posted:
2022-03-23
First Post:
2014-04-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Safety and Tolerability Study of Belumosudil (KD025) Treatment in Subjects With Moderately Severe Psoriasis Vulgaris
Sponsor:
Kadmon Corporation, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04
Start Date Type:
None
Primary Completion Date:
2014-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-09
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-02
First Submit QC Date:
None
Study First Post Date:
2014-04-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-08-13
Results First Submit QC Date:
None
Results First Post Date:
2021-09-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2014-10-20
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2022-03-15
Last Update Post Date:
2022-03-23
Last Update Post Date Type:
ACTUAL